• 9322 Citations
  • 35 h-Index
19972019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Balazs Halmos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles
Lung Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Mutation Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Lung Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 1997 2019

Changes in store for early-stage non-small cell lung cancer

Sandler, J. E., D'Aiello, A. & Halmos, B., Jan 1 2019, In : Journal of Thoracic Disease. 11, 5, p. 2117-2125 9 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Biomarkers
Molecular Targeted Therapy
Adjuvant Chemotherapy
Standard of Care

Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma

Sukrithan, V., Sandler, J., Gucalp, R. A., Gralla, R. J. & Halmos, B., Jan 1 2019, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Tumor Burden
Immunotherapy
Carcinoma
Lung
pembrolizumab
3 Citations (Scopus)

Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)

Halmos, B., Tan, E. H., Soo, R. A., Cadranel, J., Lee, M. K., Foucher, P., Hsia, T. C., Hochmair, M., Griesinger, F., Hida, T., Kim, E., Melosky, B., Märten, A. & Carcereny, E., Jan 1 2019, In : Lung Cancer. 127, p. 103-111 9 p.

Research output: Contribution to journalArticle

Safety
Mutation
Lung
Treatment Failure
Incidence
Vulnerable Populations
Primary Care Physicians
Lung Neoplasms
Primary Health Care
Mortality

Survival Disparities in Black Patients With EGFR-mutated Non–small-cell Lung Cancer

Cheng, H., Hosgood, H. D., Deng, L., Ye, K., Su, C., Sharma, J. N., Yang, Y., Halmos, B. & Perez-Soler, R., Jan 1 2019, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Survival
Weights and Measures